Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Sydney, NSW-based SWAN Genomics operates in Biotechnology Research. The record marks it privately held. Two addresses sit on record, spread over two office countries. It employs 11 people, on the record. It lists genomics and Sequencing among its specialties. One Australian registration (ABN) is a confirmed match. Its latest round on record is Grant, US$314.6K. It is listed alongside seven similar brands, mostly in Biotechnology Research.
ABN66666947253
| SWAN GENOMICS PTY LTD | ABN 66666947253 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Swan Genomics is an early stage, multi-disciplinary startup focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data to existing and new markets.
| Countries | 2 |
|---|---|
| Primary country | AU |
All codes: AU US
| Rounds | 3 |
|---|---|
| Axis | 2023 to 2026 |
| Grant · 11 Apr 2025 | US$ 314.6K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One New South Wales entity on the ABR: SWAN GENOMICS PTY LTD (ABN 66 666 947 253), high confidence.
11 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Two addresses on record across 2 countries. Primary: Sydney, NSW 2052.
Three rounds. Latest 11 April 2025: grant, US$314,600.
One tag on the brand's own list, among them Genomics and Sequencing.
Seven peer profiles on record: Endo Axiom and EntoZyme.